EcoDrugPlus

Retinoic Acid Receptor Alpha

Ensembl ID : ENSMMSG00000023636
Gene Symbol: RARA
1 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSMMSG00000001288
Gene Symbol: RARB
1 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSMMSG00000022717
Gene Symbol: RARG
1 Cross references
445 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSMMSG00000018177
Gene Symbol: RXRA
1 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSMMSG00000023046
Gene Symbol: RXRB
1 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSMMSG00000000066
Gene Symbol: RXRG
1 Cross references
273 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSMMSG00000008484
Gene Symbol: RPL11
1 Cross references
158 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSMMSG00000004343
Gene Symbol: RPL18
1 Cross references
321 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSMMSG00000020480
Gene Symbol: RPL18A
1 Cross references
178 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSMMSG00000020742
Gene Symbol: RPL19
1 Cross references
241 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSMMSG00000007170
Gene Symbol: RPL22
1 Cross references
94 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSMMSG00000020357
Gene Symbol: RPL23
1 Cross references
240 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).